Cognitive-behavioural therapy for schizophrenia: filling the therapeutic vacuum
Turkington, Douglas, Kingdon, David and Chadwick, Paul (2003) Cognitive-behavioural therapy for schizophrenia: filling the therapeutic vacuum. British Journal of Psychiatry, 183, (2), 98-99.
Full text not available from this repository.
D.T. has accepted hospitality from Pfizer, Lilly, Janssen and Organon. He has undertaken a consultancy for Pfizer, has sat on two advisory boards and has acted as principal investigator on a Pfizer-funded trial into the efficacy of CBT in schizophrenia in community settings. D.K. has received hospitality from Pfizer, Lilly and Janssen and has sat on an advisory board for Pfizer.
|Subjects:||R Medicine > RC Internal medicine > RC0321 Neuroscience. Biological psychiatry. Neuropsychiatry
B Philosophy. Psychology. Religion > BF Psychology
|Divisions:||University Structure - Pre August 2011 > School of Medicine > Clinical Neurosciences
University Structure - Pre August 2011 > School of Psychology > Superseded - please use new divisions
|Date Deposited:||07 Jul 2006|
|Last Modified:||01 Jun 2011 04:35|
|Contributors:||Turkington, Douglas (Author)
Kingdon, David (Author)
Chadwick, Paul (Author)
|Contact Email Address:||D.Kingdon@soton.ac.uk|
|RDF:||RDF+N-Triples, RDF+N3, RDF+XML, Browse.|
Actions (login required)